| Reference |
Age/Sex |
GBS subtype |
CD4 (cells/mm3) |
IVIG given |
PLEX given |
ART given |
Outcome |
| Cornblath et al. [11] |
22M |
CIDP |
Not specified |
No |
Yes |
No |
Multiple relapses despite PLEX and prednisone; took prednisone with recurrences; died of homicide months after presentation |
| |
31M |
CIDP |
Not specified |
No |
No |
No |
Relapsing course; received prednisone and had resolution of symptoms |
| |
24M |
CIDP |
Not specified |
No |
No |
No |
Relapsing course; recovered without treatment |
| |
45M |
CIDP |
Not specified |
No |
Yes |
No |
PLEX resulted in improvement of neurological symptoms to nearly normal |
| |
37M |
CIDP |
Not specified |
No |
No |
No |
Recovered without treatment |
| |
29F |
CIDP |
Not specified |
No |
No |
No |
Clinical remission with prednisone |
| |
18M |
AIDP |
Not specified |
No |
Yes |
No |
Improvement of symptoms |
| |
27M |
AIDP |
Not specified |
No |
Yes |
No |
Improvement of symptoms |
| |
26M |
AIDP |
Not specified |
No |
Yes |
No |
Improvement of symptoms |
| Hagberg et al. [23] |
56M |
AIDP |
Not specified |
No |
No |
No |
Improvement of symptoms within 4 weeks; able to walk without support at 8 weeks |
| |
69M |
AIDP |
Not specified |
No |
No |
No |
On the ventilator for 12 weeks; resolution of weakness in upper extremities and improvement in lower extremities 5 months later |
| Vendrell et al. [24] |
42M |
AIDP |
Not specified |
No |
Yes |
No |
Improvement of motor weakness by 4 months; moderate quadriparesis 6 months after symptom onset |
| Conlon [25] |
28F |
AIDP |
Not specified |
No |
No |
No |
Died 5 weeks after symptom onset due to ventilator-associated pneumonia |
| |
19F |
AIDP |
Not specified |
No |
No |
No |
Gradual improvement over several weeks, then lost to follow-up |
| |
29F |
AIDP |
Not specified |
No |
No |
No |
Able to walk with support 1 month after symptom onset |
| Franciotta et al. [26] |
25M |
AIDP |
1276 |
No |
Yes |
No |
Partially improved neurological symptoms with moderate tetraparesis 5 months after symptom onset |
| Qureshi et al. [13] |
30M |
AIDP |
5 |
No |
Yes |
No |
Unable to walk without assistance 1 year after symptom onset |
| |
33M |
AIDP |
4 |
Yes |
No |
No |
Strength improved; required a cane to ambulate 1 year after symptom onset |
| Hassan and Mathew [27] |
27M |
AIDP |
Not specified |
Yes |
No |
No |
Complete recovery by week 4 after symptom onset |
| Bani-Sadr et al. [28] |
35M |
AIDP |
149 |
No |
No |
AZT/3TC/RTV/IDV |
Complete recovery within 2 months from ART initiation |
| Brannagan and Zhou [20] |
Not specified |
AIDP |
680 |
No |
No |
No |
Good recovery with mild dysesthesias |
| |
Not specified |
AIDP |
300 |
No |
Yes |
No |
Good recovery; recurrent episodes developed 4 years later, responding to IVIG |
| |
Not specified |
AIDP |
430 |
No |
Yes |
No |
Full recovery |
| |
Not specified |
AIDP |
118 |
No |
Yes |
No |
Good recovery with dysesthesias |
| |
Not specified |
AIDP |
800 |
Yes |
No |
No |
Good recovery – able to ambulate; recurrence 10 weeks later – requires steroids and IVIG |
| |
Not specified |
AIDP |
685 |
Yes |
No |
No |
Good recovery; recurrence and paralysis after 9 weeks – requires steroids and IVIG |
| |
Not Specified |
AIDP |
175 |
Yes |
No |
AZT |
Died 18 days after symptom onset due to cardiac arrest |
| |
Not specified |
AIDP |
190 |
No |
Yes |
Yes (regimen not specified) |
Good recovery with mild residual weakness |
| |
Not specified |
AIDP |
55 |
Yes |
No |
Yes (regimen not specified) |
Good recovery with mild residual weakness |
| |
Not specified |
AIDP |
240 |
No |
Yes |
Yes (regimen not specified) |
Weakness and reflexes recovered; dysesthesias present |
| Kumar et al. [29] |
21M |
AIDP |
Not specified |
No |
Yes |
No |
Functionally independent at 3-month follow-up; complete resolution at 4-year follow-up |
| Aggarwal et al. [30] |
30M |
AIDP |
400 |
No |
No |
No |
Patient left the hospital against medical advice |
| Gisslén et al. [19] |
35M |
AIDP |
914 |
Yes |
No |
D4T/3TC/SQV/NLF |
Improvement 3 months after symptom onset; ART stopped; AIDP recurred 2 months later; IVIG and ART started; symptoms resolved in 7 months; ART discontinued and no recurrence |
| de Castro et al. [31] |
38M |
AIDP |
502 |
Yes |
Yes |
AZT/3TC/IDV, then AZT/3TC/RTV, then AZT/3TC/EFV |
Two recurrences due to interruption of ART, followed by complete recovery, which was sustained over 3 years when adherent to ART |
| Wagner and Bromberg [15] |
46M |
AMAN |
150 |
No |
No |
Yes (regimen not specified) |
Complete recovery 12 months after symptom onset |
| Hiraga et al. [32] |
56M |
FS/GBS |
24 |
Yes |
No |
Yes (regimen not specified) |
Complete recovery with continued ART |
| Sloan et al. [33] |
30M |
AIDP |
408 |
Yes |
No |
AZT/3TC/EFV |
Complete recovery after 6 months, even after cessation of ART after 6 months |
| Kumar et al. [34] |
38M |
AIDP |
280 |
Yes |
No |
AZT/3TC/EFV |
Death due to severe respiratory distress during initial hospital stay |
| Pontali et al. [35] |
56M |
AIDP |
710 |
Yes |
No |
No |
Death on day 8 of hospital stay due to cardiac arrest |
| Schreiber et al. [9] |
45F |
AIDP |
334 |
Yes |
No |
No |
Complete recovery 5 months after symptom onset |
| Nishijima et al. [36] |
33M |
AMAN |
334 |
Yes |
No |
LPV/RTV/TDF/FTC |
Able to walk with a cane after 15 months of rehabilitation |
| *Kume et al. [37] |
47M |
CIDP |
466 |
No |
No |
Yes (regimen not specified) |
Near complete recovery, with mild dysesthesias and normal NCS 6 months after symptom onset; improvement sustained after 2 years of follow-up |
| Current case |
20M |
AIDP |
213 |
Yes |
Yes |
TDF/FTC/RAL |
Recurrent episodes of AIDP, with progression to CIDP; near complete recovery 12 months after symptom onset |
*Article in Japanese; data derived from English abstract.